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miCLIPAbstract RNA–protein interactions inﬂuence many biological processes. Identifying the binding
sites of RNA-binding proteins (RBPs) remains one of the most fundamental and important chal-
lenges to the studies of such interactions. Capturing RNA and RBPs via chemical crosslinking
allows stringent puriﬁcation procedures that signiﬁcantly remove the non-speciﬁc RNA and protein
interactions. Two major types of chemical crosslinking strategies have been developed to date, i.e.,
UV-enabled crosslinking and enzymatic mechanism-based covalent capture. In this review, we com-
pare such strategies and their current applications, with an emphasis on the technologies themselves
rather than the biology that has been revealed. We hope such methods could beneﬁt broader audi-
ence and also urge for the development of new methods to study RNARBP interactions.Introduction
RNAs undergo multiple RBP-mediated processing and regula-
tory steps to exert their biological functions. To understand
RNA processing and regulation, great efforts have been madeto study protein–RNA interactions in the cellular context.
Among many strategies that have been developed, mapping
RNA–protein interactions on a genomic scale (thus often cou-
pled with high-throughput analyses) represents one great exam-
ple. In the initial attempts to identify RNAs that are bound by
speciﬁc RBPs, RNA immunoprecipitation was combined with
microarray analysis (RIP-ChIP) [1,2]. However, these methods
are limited to stable ribonucleoprotein particles (RNPs), which
are prone to contamination of indirect or non-physiological
interactions [3]. In order to achieve high speciﬁcity (and also res-
olution), methods that allow covalent capture of RNA–protein
interactions in vivo have been developed. In the following sec-
tions, we will describe these novel methods for mapping the
binding sites of RBPs on a genome-wide scale.hosting
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enabled by UV crosslinking
CLIP and HITS-CLIP
UV cross-linking and immunoprecipitation (CLIP) is a mile-
stone technology invented by the Darnell Laboratory in 2003
(Figure 1) [4]. Back in the 1980s, it was reported that UV light
induces covalent crosslinks between proteins and RNAs, with-
out causing crosslinks between proteins [5,6]. CLIP makes use
of short wave UV irradiation at 254 nm to induce the formation
of covalent crosslinks only at sites of direct contact between pro-
teins and RNAs, in the context of whole tissues, organisms or
individual cell types. After UV irradiation, cells are lysed and
the cross-linked RNA–RBP is ﬁrst treated with RNase to trim
the RNA size to about 60–100 nucleotides in length. Since the
protein–RNAcomplex is covalently linked, stringent conditions
can be applied during immunoprecipitation to purify the pro-
tein–RNA complexes. Such immunoprecipitation procedure is
generally enabledwith antibodies against the proteins of interest
or protein epitope tags. Subsequently, the protein–RNA com-
plexes are separated on SDS–polyacrylamide gel electrophoresis
(SDS–PAGE), and transferred to nitrocellulose membrane fol-
lowed by proteinaseK treatment. Such step also helps to remove
contamination caused by the antibody or during immunopre-
cipitation step. The RNA molecules recovered are then 50 and
30 ligated, allowing PCR ampliﬁcation of the target RNA from
RNPs of interest.
This original CLIP protocol was ﬁrst applied to identify
Nova RNA targets in the brain by the Darnell group [4]. Nova
is a neuron-speciﬁc RBP, which regulates neuronal RNA splic-
ing. In 2005, Darnell and colleagues optimized the original
CLIP protocol and further improved the speciﬁcity of the
method. In the current CLIP protocol, the 30 RNA linker
ligation step is done on-bead [7]. There are three advantages
conferred by this modiﬁcation. First, free 30-linkers can be
removed during SDS–PAGE, so that it can prevent the liga-
tion of 50-linker and 30-linker, self-ligation, circularization of
target RNA and the ligation of bacterial rRNA that may come
from the commercial RNA ligase or proteinase K. Therefore,
signal-to-noise ratio can be greatly improved. Second, there
is no need to separate free RNAs on urea–PAGE, which is a
necessary step to separate linkerlinker ligation from previous
CLIP protocol. Third, the usage of high concentration of
RNA linkers can be avoided, which alleviates the aforemen-
tioned self-ligation problem as well. In 2008, a new modiﬁca-
tion to CLIP, high-throughput sequencing of RNA isolated
by crosslinking immunoprecipitation (HITS-CLIP), was
adopted to harness the power of next-generation sequencing
(NGS). Thus, HITS-CLIP has made it highly feasible to obtain
genome-wide protein–RNA interactions. HITS-CLIP was ﬁrst
applied to study Nova–RNA interactions and uncovered the 3’
end RNA processing rules in the brain [8].
Control experiments are key components in every tech-
nique, and CLIP or HITS-CLIP is no exception. There are
two essential controls in CLIP or HITS-CLIP. First, to verify
that UV light has indeed caused covalent crosslinks between
proteins and RNA, a non-UV treated sample should be used
for immunoprecipitation, in which no RNA should be
detected. Second, the antibody that recognizes the protein of
interest must be speciﬁc. Therefore, it is very necessary torun a control without antibody, or a control with knockout
cell or tissue, and do a mock IP experiment.
Apart from Nova, the RNA targets of several RBPs have
been successfully identiﬁed by CLIP or HITS-CLIP in vari-
ous biological systems. For example, with the help of the
CLIP method, hnRNP A1, a nucleo-cytoplasmic shuttling
protein, is shown to be required for processing of miR-18a
[9] and SF2/ASF, a prototype member of the SR protein
family, was reported to regulate processing of speciﬁc
mRNAs with the help of CLIP [10]. CLIP was also used to
study the function of the RNA-binding protein Rrm4, discov-
ering that Rrm4 may transport RNAs from the nucleus to
cell poles [11]. Additionally, HITS-CLIP was also applied
to study other RBPs, such as Argonaute in mouse brain
[12], polypyrimidine tract-binding protein (PTB, also known
as hnRNP I) in HeLa cells [13], FOX2 in human embryonic
stem cells [14] and so on.
Nonetheless, HITS-CLIP and CLIP methods discussed
above cannot achieve individual-nucleotide resolution of the
binding site. In 2011, it was reported that the cross-linked
nucleotide could be deleted or mutated during reverse tran-
scription [15,16]. Therefore, through the analysis of deletion
or mutation in sequencing reads, HITS-CLIP can identify
exact crosslink sites and achieve individual-nucleotide resolu-
tion of the binding site (Figure 1) [15,16].
In summary, CLIP and HITS-CLIP are very useful tech-
niques to study protein–RNA interactions, which can be
applied to different biological samples such as bacteria, fungi,
yeast, Caenorhabditis elegans, mammalian tissue including
brain, and culture cells including human embryonic stem cells
and HeLa cells.
PAR-CLIP
It was estimated that in CLIP or HITS-CLIP, the maximal
crosslinking efﬁciency ranges from 1% to 5% with puriﬁed
protein and radiolabeled RNA [17]. To improve the cross-
linking efﬁciency, photoactive nucleoside analogues, 4-thio-
uridine (4-SU) and 6-thioguanosine (6-SG), and hence
photoactivatable ribonucleoside-enhanced CLIP (PAR-
CLIP) were used by Tuschl and colleagues [18]. In PAR-
CLIP, 4-SU and 6-SG are added to the growth medium,
which are then taken up by cells and eventually incorpo-
rated into newly-synthesized RNA molecules without obvi-
ous toxicity. The formation of covalent crosslinks between
proteins and RNAs is performed under UV irradiation at
365 nm, instead of UV 254 nm used in CLIP. The following
steps are similar to CLIP protocol, including RNase treat-
ment, immunoprecipitation, recovery of RNA fragment,
reverse transcription and sequencing.
It is noteworthy that the incorporated 4-SU can lead to T
to C transition in the sequenced cDNA. Therefore, it is pos-
sible to identify crosslink sites at individual-nucleotide resolu-
tion by analyzing the mutations in cDNA sequences
(Figure 1). The accuracy of PAR-CLIP has been veriﬁed by
identifying the RNA targets of several RBPs in recent years.
At the very beginning, Thomas Tuschl and colleagues
selected several intensely-studied RBPs and microRNA-con-
taining RNP complexes (miRNPs), including pumilio homo-
logue 2 (PUM2), quaking (QKI), insulin-like growth factor
2 mRNA-binding proteins 1–3 (IGF2BP1–3), the Argonaute
proteins (AGO) and trinucleotide repeat-containing proteins
Figure 1 Outline of HITS-CLIP, PAR-CLIP and several variants, iCLIP, iCLAP and CRAC
High-throughput sequencing CLIP (HITS-CLIP) and individual-nucleotide resolution CLIP (iCLIP) are in the left panels; individual-
nucleotide resolution crosslinking afﬁnity puriﬁcation (iCLAP) and crosslinking and cDNA analysis (CRAC) are in the middle panels;
photoactivatable ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) is in the right panel. PAR-CLIP uses
thioribonucleosides and UV at 365 nm to form the complex of RNA and RNA-binding protein (RBP), while the other four methods
utilize UV at 254 nm. Isolation of RNA–RBP complexes is achieved either by immunoprecipitation (IP) (PAR-CLIP, HITS-CLIP and
iCLIP) or by double afﬁnity puriﬁcation (iCLAP and CRAC). iCLAP and CRAC use immobilized metal ion afﬁnity chromatography
(IMAC) under denaturing conditions as a secondary puriﬁcation. To achieve individual-nucleotide resolution, HITS-CLIP utilizes
deletion or mutation during reverse transcription, iCLIP and iCLAP take advantage of truncated cDNAs, and PAR-CLIP makes use of
thymidine (T) to cytidine (C) transition in cDNA. TEV, tobacco etch virus; ProtA, Staphylococcus aureus protein A.
74 Genomics Proteomics Bioinformatics 12 (2014) 72–786 (TNRC6AC) in HEK293 cells, to identify the binding
sites [18]. One year later, transcriptome-wide binding sites
of the RBP defective germline development protein 1
(GLD-1) in C. elegans [19], RNA targets of the RNA-bindingprotein HuR [16,20,21], the binding targets of the sequence-
speciﬁc RBP complex Nrd1 and Nab3 in yeast [22] and the
binding motif of PAP-associated domain-containing 5
(PAPD5) [23] were also identiﬁed using PAR-CLIP.
Li X et al / Crosslinking RNA-protein Interactions Genome-wide 75In addition, PAR-CLIP is particularly suitable for studies
using cultured cells, because of its high uptake efﬁciency of
nucleoside analogues (incorporation efﬁciency is up to 4%
for 4-SU in relative to uridine [18]). In short, the PAR-CLIP
method has higher cross-linking efﬁciency and can also achieve
individual-nucleotide resolution of the binding sites.CLIP-derived methods
In the case of the protein Nova, 85% of cDNAs are truncated,
because reverse transcriptase stops at the UV-induced cross-
link site, in which peptides may not be removed by proteinase
K [24]. However, every coin has two sides. Individual-nucleo-
tide resolution CLIP (iCLIP), a variation of CLIP, was devel-
oped by the Ule laboratory, which made use of this
experimental observation to identify crosslinked sites [25]. In
iCLIP protocol, co-immunoprecipitated RNA is ligated to a
30 adaptor, followed by proteinase K treatment, resulting in
a covalently-bound peptide on the RNA. Using primers con-
taining two cleavable adaptor regions and one random bar-
code, cDNA will be truncated at crosslink site during reverse
transcription. Subsequently, cDNA is circularized, linearized,
ampliﬁed and sequenced. Thus, it is easy to ﬁnd out the residue
next to the crosslink site, which ideally should be the ﬁrst
nucleotide after the barcoded sequence (Figure 1). iCLIP was
ﬁrst applied to study the function of hnRNP in splicing [25].
Subsequently, this technique was used to identify the RNA tar-
gets of the T-cell-restricted intracellular antigen-1 (TIA1),
TIA-like 1 (TIAL1) [26] and TAR DNA-binding protein 43
(TDP-43) [27].
Crosslinking and afﬁnity puriﬁcation (iCLAP), a method to
purify streptavidin/histidine (Strep/His) double-tagged RBP
using stringent afﬁnity puriﬁcation instead of immunoprecipi-
tation, is a variation of iCLIP (Figure 1). In the case of TIA1
and TIAL1, the TIA1 antibody has a slight cross-reactivity
during afﬁnity puriﬁcation to TIAL1 [26]. Therefore, it is
necessary to use RBP with a tag at the N- or C-terminus to
co-purify the RNP complex, under the conditions of poor anti-
bodies. In the iCLAP technique, Jernej Ule and colleagues,
who invented the iCLIP method, used magnetic streptavidin
beads in the ﬁrst puriﬁcation step followed by cobalt beads
under denaturing conditions as a secondary puriﬁcation step
[26]. Subsequently, cDNAs are ampliﬁed and sequenced in
the similar way as using iCLIP.
Another variation of CLIP is the crosslinking and cDNA
analysis (CRAC), where RBPs are tagged with C-terminal
6 · His, tobacco etch virus (TEV) protease site and protein
A tags (Figure 1). Similar to iCLIP, immunoglobulin
G (IgG) beads are used in the ﬁrst puriﬁcation step. The
RNA–protein complexes were subsequently treated with
TEV protease, followed by immobilized metal-ion afﬁnity
chromatography (IMAC) as a secondary puriﬁcation. Using
the CRAC method, the Tollervey laboratory identiﬁed the
binding sites of the probable pre-mRNA-splicing factor
ATP-dependent RNA helicase Prp43 [28] and the small
nucleolar RNPs (snoRNPs) Nop1, Nop56, Nop58 and rRNA
processing 9 (Rrp9) [29] in yeast.
In summary, as CLIP variants, iCLIP, iCLAP and CRAC
are similar to HITS-CLIP and PAR-CLIP in essence. All
methods can achieve single nucleotide resolution and produce
data with high precision.Crosslinking to identify RNA-bound proteome
RBPs play diverse roles in many biological processes and inﬂu-
ence the RNA metabolism [30]. Many RBPs have canonical
RNA binding domains, including the RNA recognition motif
(RRM), heterogeneous nuclear RNP K-homology domain
(KH), zinc ﬁnger (Znf), etc. [31]. Based on such observation,
the mammalian genome has been predicted to encode about
600 RBPs [32]. However, researchers also have reported that
there are quite a few RBPs that do not contain such canonical
RNA-binding domains [23,33]. Therefore, mere computational
predictions will likely miss these non-canonical RBPs.
Two types of experiments can be performed in order to
identify an RBP. The ﬁrst one takes advantage of protein
arrays, which were spotted with tagged recombinant proteins.
In fact, two groups have identiﬁed about 200 RBPs in yeast via
protein arrays [34,35]. The other one utilizes RNA pull-down
methods, in which RNA of interest is immobilized and then
used to pull out potential RBPs from (very often) cell lysates
via afﬁnity. Combining the use of an RNA tag and high-reso-
lution quantitative mass spectrometry (MS), interacting part-
ners for RNA motifs of general interest can be detected [36].
For instance, by hybridizing with afﬁnity-tagged oligodT,
mRNA-binding proteome can be studied [37]. Nonetheless,
these methods cannot discriminate direct RNA–protein inter-
actions from indirect ones.
In 2012, two groups independently reported a new
approach to study the mRNA interactome. In the ﬁrst step
of their methods, they use UV light to covalently crosslink
RNA and RBPs. The UV light can only crosslink protein
bound to RNA directly but does not affect protein–protein
interaction. The next step involves afﬁnity puriﬁcation of
mRNAs using oligodT, instead of trimming down the RNAs
as performed in CLIP-type experiments. In this way,
mRNA-binding proteins that are covalently attached to
mRNA molecules will also be pulled down at the same time.
By high-resolution quantitative MS, mRNA interactome can
be identiﬁed in a high throughput manner. These studies have
identiﬁed about 800 RBPs, including about 300 RBPs that are
not annotated previously [38,39].
Cellular protein–RNA interactions enabled
by mechanistic crosslinking
More than 100 post-transcriptional RNA modiﬁcations have
been identiﬁed in cellular RNAs until now [40]. Yet, identify-
ing the modifying enzymes along with their physiological sites
of modiﬁcation remains a challenging task [41].
Among these RNA modiﬁcations, RNA cytosine methyla-
tion, occurring at the C5 position (m5C), has been detected in
tRNAs, rRNAs and mRNAs [42,43]. There are six families of
m5C RNA methyltransferase (RMT), but only two of them,
NOP2/Sun RMT family member 2 (NSUN2) and DNA
(cytosine-5-)-methyltransferase 2 (DNMT2), have been identi-
ﬁed in higher eukaryotes [42]. Both were known previously to
work on speciﬁc tRNA molecules [44–46]; yet the full spec-
trum of targets remains an open question for both enzymes.
To identity the target sites of these RMT, two groups sepa-
rately developed two new crosslinking methods to capture
RNA-modifying enzymes that are linked directly to their tar-
gets. Both methods involve the formation of covalent RNP
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instead of using UV-crosslinking [47,48].
It has been found that m5C-RMT could form a covalent
enzymesubstrate intermediate during the methylation reac-
tions [42]. The covalent bond is formed, at the early stage of
methylation process, between a cysteine residue of the m5C-
RMT and the C6 atom of cytosine of the RNA target. Then
the RNA methyltransferase transfers a methyl group from
cofactor S-adenosyl methionine (SAM) to the C5 of the target
cytosine (Figure 2). The enzyme is ﬁnally released by b-elimina-
tion. Interestingly, studies have shown that if the cytosine of the
RNA targets is replaced by a cytosine analogue, 5-azacytidine
(5-aza-C), the methyltransferase cannot be released from the
RNA target sites and thus remains covalently attached to its tar-
gets (Figure 2). Based on thismechanism,Khoddami andCairns
developed a mechanistic crosslinking method called Aza-IP.
They incorporated 5-aza-C into nascent RNA by feeding cells
with 5-aza-C; they then immunoprecipitated the m5C-RMT,
together with its target RNAs. Finally, the target sites can be
identiﬁed by deep sequencing and computational analysis [48].
Besides the use of cytosine analogues to trap the m5C-
RMT, mutation to the methyltransferase can also stabilize
the covalently-linked protein–RNA during the catalytic pro-
cess. For instance, Cys321 of NSUN2 can form the covalent
bond with the cytosine of the target RNA sites. Another cys-
teine at position 271 (Cys271) of NSUN2 is required for the
release of the methylated RNA. If Cys271 is mutated to ala-
nine, the methyltransferase cannot be released from the
RNA target sites (Figure 2). By utilizing such enzyme
properties, Hussain and his colleagues successfully crosslinked
the RNA targets of NSUN2; the remaining strategy forsequencing the RNA resembles those of iCLIP, therefore they
termed the method methylation iCLIP (miCLIP) [47].Towards more RNA-modifying enzymes
RNA molecules are intensively modiﬁed; yet the interactions
between RNA targets and RNA-modifying enzymes are often
transient. We discussed mechanistic crosslinking in the section
above to study interactions between RNA targets and m5C-
RMT; both ‘‘Aza-IP’’ and ‘‘miCLIP’’ rely on the detailed
knowledge of the enzymatic mechanism and the usage of either
a mechanism-based inhibitor, 5-aza-C, or mutant protein with
altered enzymatic action. However, successful examples
towards other RNA modiﬁcations and their related enzymes
are still scarce at the moment.
We will use N6-methyladenosine (m6A) RNA modiﬁcation
as an example to formulate the challenges and opportunities in
identifying, on the genomic level, protein–RNA interactions
for RNA-modifying enzymes. m6A is the most abundant
endogenous modiﬁcation for mRNA in eukaryotes [49]; and
the recent discoveries of two novel m6A demethylases have
gained renewed interest for this long-known modiﬁcation
[50,51]. The fat mass and obesity-associated protein (FTO),
which was ﬁrst identiﬁed through genome-wide association
studies to be linked to fat mass and obesity [52], shows efﬁcient
demethylation activity towards m6A [50]. Alpha-ketoglutarate-
dependent dioxygenase alkB homologue 5 (ALKBH5),
another homologue protein of FTO, was later shown to be
another m6A demethylase, which impacts RNA metabolism
and mouse fertility [51]. More recently, three labs
Li X et al / Crosslinking RNA-protein Interactions Genome-wide 77independently reported the identiﬁcation of m6A-methyltrans-
ferases [53–55]. In addition, reader proteins of m6A have been
suggested [56]. For example, the YTH domain family member
2 (YTHDF2) protein, one of the reader proteins, selectively
recognizes m6A and targets the bound mRNA to decay sites,
thereby affecting the translation status and lifetime of mRNA
[57].
Although the genome-wide characterization of m6A modi-
ﬁcation in mRNA has been reported [56,58], many open ques-
tions remain for the writer, reader and eraser proteins of the
m6A modiﬁcation. PAR-CLIP experiments have been used
to investigate the protein–RNA interactions for the writer
and reader proteins [53,57]; yet the detailed interaction proﬁles
for the eraser proteins FTO and ALKBH5 are still lacking.
Both FTO and ALKBH5 are Fe2+-dependent dioxygenases;
they also use the putative ‘‘base-ﬂipping’’ mechanism to gain
access to the target m6A base for demethylation reactions
[59]. While existing crosslinking methods might still not be able
to capture the transient interactions for these eraser proteins,
new strategies that take into account their unique enzymatic
mechanism could be useful in stabilizing protein–RNA
interactions.
Conclusion and outlook
Formation of covalent bond between protein and RNA offers
an important tool to the identiﬁcation of RNA–protein inter-
action, as covalently-crosslinked complex can bear stringent
puriﬁcation to remove nonspeciﬁcally-bound RNA and pro-
tein. While UV crosslink-based methods are preferentially used
for RBPs, mechanism-based crosslinking methods will be par-
ticularly useful for RNA-modifying enzymes, since these pro-
teins only stay transiently with their RNA targets. In this
review, we summarize technical aspects of several UV-enabled
crosslinking strategies, including HITS-CLIP, PAR-CLIP and
several derived methods with individual nucleotide-resolution.
While these methods have allowed many successful studies of
RNA–protein interactions, challenges still exist for more
robust assays. We hope our comparisons of the existing meth-
ods could really stimulate the development of new crosslinking
methods with improved crosslinking efﬁciency. Ultimately,
more high-resolution maps of RNA–protein interactions can
be revealed to understand their biological roles in greater
depth and detail.
Competing interests
The authors declare no competing ﬁnancial interests.Acknowledgements
Thisworkwas supportedby theNationalNatural ScienceFoun-
dation of China (Grant No. 31270838) and the National Basic
Research Foundation of China (Grant No. 2014CB964900).
References
[1] Triﬁllis P, Day N, Kiledjian M. Finding the right RNA:
identiﬁcation of cellular mRNA substrates for RNA-binding
proteins. RNA 1999;5:1071–82.[2] Brooks SA, Rigby WFC. Characterization of the mRNA ligands
bound by the RNA binding protein hnRNP A2 utilizing a novel
in vivo technique. Nucleic Acids Res 2000;28:e49.
[3] Mili S, Steitz JA. Evidence for reassociation of RNA-binding
proteins after cell lysis: implications for the interpretation of
immunoprecipitation analyses. RNA 2004;10:1692–4.
[4] Ule J, Jensen KB, Ruggiu M, Mele A, Ule A, Darnell RB. CLIP
identiﬁes Nova-regulated RNA networks in the brain. Science
2003;302:1212–5.
[5] Wagenmakers AJ, Reinders RJ, van Venrooij WJ. Cross-linking
of mRNA to proteins by irradiation of intact cells with ultraviolet
light. Eur J Biochem 1980;112:323–30.
[6] Pinol-Roma S, Adam SA, Choi YD, Dreyfuss G. Ultraviolet-
induced cross-linking of RNA to proteins in vivo. Methods
Enzymol 1989;180:410–8.
[7] Ule J, Jensen K, Mele A, Darnell RB. CLIP: a method for
identifying protein–RNA interaction sites in living cells. Methods
2005;37:376–86.
[8] Licatalosi DD, Mele A, Fak JJ, Ule J, Kayikci M, Chi SW, et al.
HITS-CLIP yields genome-wide insights into brain alternative
RNA processing. Nature 2008;456:464–9.
[9] Guil S, Ca´ceres JF. The multifunctional RNA-binding protein
hnRNP A1 is required for processing of miR-18a. Nat Struct Mol
Biol 2007;14:591–6.
[10] Sanford JR, Coutinho P, Hackett JA, Wang X, Ranahan W,
Caceres JF. Identiﬁcation of nuclear and cytoplasmic mRNA
targets for the shuttling protein SF2/ASF. PLoSOne 2008;3:e3369.
[11] Becht P, Ko¨nig J, Feldbru¨gge M. The RNA-binding protein Rrm4
is essential for polarity in Ustilago maydis and shuttles along
microtubules. J Cell Sci 2006;119:4964–73.
[12] Chi SW, Zang JB, Mele A, Darnell RB. Argonaute HITS-CLIP
decodes microRNA-mRNA interaction maps. Nature
2009;460:479–86.
[13] Xue Y, Zhou Y, Wu T, Zhu T, Ji X, Kwon YS, et al. Genome-
wide analysis of PTB-RNA interactions reveals a strategy used by
the general splicing repressor to modulate exon inclusion or
skipping. Mol Cell 2009;36:996–1006.
[14] Yeo GW, Coufal NG, Liang TY, Peng GE, Fu XD, Gage FH. An
RNA code for the FOX2 splicing regulator revealed by mapping
RNA–protein interactions in stem cells. Nat Struct Mol Biol
2009;16:130–7.
[15] Zhang C, Darnell RB. Mapping in vivo protein–RNA interactions
at single-nucleotide resolution from HITS-CLIP data. Nat Bio-
technol 2011;29:607–14.
[16] Kishore S, Jaskiewicz L, Burger L, Hausser J, Khorshid M,
Zavolan M. A quantitative analysis of CLIP methods for
identifying binding sites of RNA-binding proteins. Nat Methods
2011;8:559–64.
[17] Darnell RB. HITS-CLIP: panoramic views of protein–RNA
regulation in living cells. Wiley Interdiscip Rev RNA
2010;1:266–86.
[18] Hafner M, Landthaler M, Burger L, Khorshid M, Hausser J,
Berninger P, et al. Transcriptome-wide identiﬁcation of RNA-
binding protein and microRNA target sites by PAR-CLIP. Cell
2010;141:129–41.
[19] Jungkamp AC, Stoeckius M, Mecenas D, Gru¨n D, Mastrobuoni
G, Kempa S, et al. In vivo and transcriptome-wide identiﬁcation
of RNA binding protein target sites. Mol Cell 2011;44:828–40.
[20] Mukherjee N, Corcoran DL, Nusbaum JD, Reid DW, Georgiev
S, Hafner M, et al. Integrative regulatory mapping indicates that
the RNA-binding protein HuR couples pre-mRNA processing
and mRNA stability. Mol Cell 2011;43:327–39.
[21] Lebedeva S, Jens M, Theil K, Schwanha¨usser B, Selbach M,
Landthaler M, et al. Transcriptome-wide analysis of regulatory
interactions of the RNA-binding protein HuR. Mol Cell
2011;43:340–52.
[22] Jamonnak N, Creamer TJ, Darby MM, Schaughency P, Wheelan
SJ, Corden JL. Yeast Nrd1, Nab3, and Sen1 transcriptome-wide
78 Genomics Proteomics Bioinformatics 12 (2014) 72–78binding maps suggest multiple roles in post-transcriptional RNA
processing. RNA 2011;17:2011–25.
[23] Rammelt C, Bilen B, Zavolan M, Keller W. PAPD5, a nonca-
nonical poly(A) polymerase with an unusual RNA-binding motif.
RNA 2011;17:1737–46.
[24] Sugimoto Y, Ko¨nig J, Hussain S, Zupan B, Curk T, Frye M,
et al. Analysis of CLIP and iCLIP methods for nucleotide-
resolution studies of protein–RNA interactions. Genome Biol
2012;13:1–13.
[25] Konig J, Zarnack K, Rot G, Curk T, Kayikci M, Zupan B, et al.
ICLIP reveals the function of hnRNP particles in splicing at
individual nucleotide resolution. Nat Struct Mol Biol
2010;17:909–15.
[26] Wang Z, Kayikci M, Briese M, Zarnack K, Luscombe NM, Rot
G, et al. ICLIP predicts the dual splicing effects of TIA-RNA
interactions. PLoS Biol 2010;8:e1000530.
[27] Tollervey JR, Curk T, Rogelj B, Briese M, Cereda M, Kayikci M,
et al. Characterizing the RNA targets and position-dependent
splicing regulation by TDP-43. Nat Neurosci 2011;14:452–8.
[28] Bohnsack MT, Martin R, Granneman S, Ruprecht M, Schleiff E,
Tollervey D. Prp43 bound at different sites on the pre-rRNA
performs distinct functions in ribosome synthesis. Mol Cell
2009;36:583–92.
[29] Granneman S, Kudla G, Petfalski E, Tollervey D. Identiﬁcation
of protein binding sites on U3 snoRNA and pre-rRNA by UV
cross-linking and high-throughput analysis of cDNAs. Proc Natl
Acad Sci U S A 2009;106:9613–8.
[30] Glisovic T, Bachorik JL, Yong J, Dreyfuss G. RNA-binding
proteins and post-transcriptional gene regulation. FEBS Lett
2008;582:1977–86.
[31] Lunde BM, Moore C, Varani G. RNA-binding proteins: modular
design for efﬁcient function. Nat RevMol Cell Biol 2007;8:479–90.
[32] de Lima Morais DA, Fang H, Rackham OJ, Wilson D, Pethica R,
Chothia C, et al. SUPERFAMILY 1.75 including a domain-
centric gene ontologymethod.NucleicAcidsRes 2011;39:D427–34.
[33] Lee I, Hong W. RAP – a putative RNA-binding domain. Trends
Biochem Sci 2004;29:567–70.
[34] Tsvetanova NG, Klass DM, Salzman J, Brown PO. Proteome-
wide search reveals unexpected RNA-binding proteins in Saccha-
romyces cerevisiae. PloS One 2010;5:e12671.
[35] Scherrer T, Mittal N, Janga SC, Gerber AP. A screen for RNA-
binding proteins in yeast indicates dual functions for many
enzymes. PloS One 2010;5:e15499.
[36] Butter F, Scheibe M, Mo¨rl M, Mann M. Unbiased RNA-protein
interaction screen by quantitative proteomics. Proc Natl Acad Sci
U S A 2009;106:10626–31.
[37] Lindberg U, Sundquist B. Isolation of messenger ribonucleopro-
teins from mammalian cells. J Mol Biol 1974;86:451–68.
[38] Castello A, Fischer B, Eichelbaum K, Horos R, Beckmann BM,
Strein C, et al. Insights into RNA biology from an atlas of
mammalian mRNA-binding proteins. Cell 2012;149:1393–406.
[39] Baltz AG, Munschauer M, Schwanhausser B, Vasile A, Murak-
awa Y, Schueler M, et al. The mRNA-bound proteome and its
global occupancy proﬁle on protein-coding transcripts. Mol Cell
2012;46:674–90.
[40] Cantara WA, Crain PF, Rozenski J, McCloskey JA, Harris KA,
Zhang X, et al. The RNA modiﬁcation database, RNAMDB:
2011 update. Nucleic Acids Res 2011;39:D195–201.
[41] He C. Grand challenge commentary: RNA epigenetics? Nat Chem
Biol 2010;6:863–5.[42] Motorin Y, Lyko F, Helm M. 5-methylcytosine in RNA:
detection, enzymatic formation and biological functions. Nucleic
Acids Res 2010;38:1415–30.
[43] Squires JE, Patel HR, Nousch M, Sibbritt T, Humphreys DT,
Parker BJ, et al. Widespread occurrence of 5-methylcytosine in
human coding and non-coding RNA. Nucleic Acids Res
2012;40:5023–33.
[44] Jurkowski TP, Meusburger M, Phalke S, Helm M, Nellen W,
Reuter G, et al. Human DNMT2 methylates tRNA(Asp) mole-
cules using a DNA methyltransferase-like catalytic mechanism.
RNA 2008;14:1663–70.
[45] Schaefer M, Pollex T, Hanna K, Tuorto F, Meusburger M, Helm
M, et al. RNA methylation by Dnmt2 protects transfer RNAs
against stress-induced cleavage. Genes Dev 2010;24:1590–5.
[46] Tuorto F, Liebers R, Musch T, Schaefer M, Hofmann S, Kellner
S, et al. RNA cytosine methylation by Dnmt2 and NSun2
promotes tRNA stability and protein synthesis. Nat Struct Mol
Biol 2012;19:900–5.
[47] Hussain S, Sajini AA, Blanco S, Dietmann S, Lombard P,
Sugimoto Y, et al. NSun2-mediated cytosine-5 methylation of
vault noncoding RNA determines its processing into regulatory
small RNAs. Cell Rep 2013;4:255–61.
[48] Khoddami V, Cairns BR. Identiﬁcation of direct targets and
modiﬁed bases of RNA cytosine methyltransferases. Nat Bio-
technol 2013;31:458–64.
[49] Grosjean H. Fine-tuning of RNA functions by modiﬁcation and
editing, XXIV. New York: Springer; 2005, p. 442.
[50] Jia G, Fu Y, Zhao X, Dai Q, Zheng G, Yang Y, et al. N6-
methyladenosine in nuclear RNA is a major substrate of the
obesity-associated FTO. Nat Chem Biol 2011;7:885–7.
[51] Zheng G, Dahl JA, Niu Y, Fedorcsak P, Huang CM, Li CJ, et al.
ALKBH5 is a mammalian RNA demethylase that impacts RNA
metabolism and mouse fertility. Mol Cell 2013;49:18–29.
[52] Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy
RM, Lindgren CM, et al. A common variant in the FTO gene is
associated with body mass index and predisposes to childhood
and adult obesity. Science 2007;316:889–94.
[53] Liu J, Yue Y, Han D, Wang X, Fu Y, Zhang L, et al. A
METTL3-METTL14 complex mediates mammalian nuclear
RNA N6-adenosine methylation. Nat Chem Biol 2014;10:93–5.
[54] Ping XL, Sun BF, Wang L, Xiao W, Yang X, Wang WJ, et al.
Mammalian WTAP is a regulatory subunit of the RNA N6-
methyladenosine methyltransferase. Cell Res 2014;24:177–89.
[55] Wang Y, Li Y, Toth JI, Petroski MD, Zhang Z, Zhao JC. N6-
methyladenosine modiﬁcation destabilizes developmental regula-
tors in embryonic stem cells. Nat Cell Biol 2014;16:191–8.
[56] Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-
Divon M, Ungar L, Osenberg S, et al. Topology of the human
and mouse m6A RNA methylomes revealed by m6A-seq. Nature
2012;485:201–6.
[57] Wang X, Lu Z, Gomez A, Hon GC, Yue Y, Han D, et al. N6-
methyladenosine-dependent regulation of messenger RNA stabil-
ity. Nature 2014;505:117–20.
[58] Meyer KD, Saletore Y, Zumbo P, Elemento O, Mason CE,
Jaffrey SR. Comprehensive analysis of mRNA methylation
reveals enrichment in 30 UTRs and near stop codons. Cell
2012;149:1635–46.
[59] Yi C, He C. DNA repair by reversal of DNA damage. Cold
Spring Harb Perspect Biol 2013;5:a012575.
